B-cell acute lymphoblastic leukemia (B-ALL) is one of the most common forms of childhood cancer. The overall survival rate is more than 80%, but not in all subtypes; in leukemia with the highest incidence among infants, in ...
Sep 27, 2023
0
17
Precision medicine seeks to adapt treatments to the characteristics of each patient. Genome studies are providing more and more data to achieve this, but this very abundance of information is hampering the task: Doctors must ...
Jun 20, 2023
0
5
15 years ago, a woman in her thirties was diagnosed with metastatic kidney cancer. The oncologist José Pablo Maroto, from the Hospital de la Santa Creu i Sant Pau, in Barcelona, decided to treat her with the drug temsirolimus, ...
Jun 14, 2023
0
2
Diet influences the incidence, growth and progression of cancer, to the extent that one-third of the most common cancers can be prevented, at least in part, by dietary changes. And indeed, preclinical studies using food as ...
Jun 1, 2023
0
14
Researchers at the CNIO (Spanish National Cancer Research Center) have discovered that one of the causes for the rare tumor pheochromocytoma-paraganglioma is the interruption of a very specific step in the production of some ...
May 9, 2023
0
10
According to recent figures published by the Spanish Society of Medical Oncology (SEOM), more than 30,000 new cases of lung cancer will be diagnosed in Spain in 2023, making it the second most frequent type of cancer in this ...
Mar 17, 2023
0
13
The drug denosumab is currently used to treat osteoporosis and bone metastases. For more than a decade, its potential therapeutic benefit in the treatment of breast cancer has also been studied. However, due to conflicting ...
Mar 7, 2023
0
5
Pheochromocytoma is a rare tumor, with an incidence of three to eight cases per million population per year. The work published today, Feb 28, on Rare Disease Day 2023, in Nature Communications, is the largest study on this ...
Feb 28, 2023
0
20
Multiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibodies. It is the second most common hematologic cancer, accounting for 2% of all cancers of hematologic origin.
Nov 9, 2022
0
14
The intestine is very susceptible and is affected by the harsh conditions caused by DNA-altering agents, such as radiation and chemotherapy, during cancer treatment. For example, many patients with tumors in the gastrointestinal ...
Sep 14, 2022
0
7
